Clinical Trial: Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218601) titled 'Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer' on Oct. 16.

Brief Summary: The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure changes in certain chemicals in the breath before and after standard neoadjuvant therapy in people with NSCLC.

Study Start Date: Oct. 10

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer

Intervention: OTHER: Breath sample collection

Cohort 1: patients undergoing neoadjuvant treatment (stages II to IIIB) will undergo breath sampling (1) at baseline before...